Showing 34,893 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Harm reduction

Prison needle programs touted to reduce HIV and Hep C

Editor's pick
Toronto Star
3 February 2016
Activism & civil society

Lawsuits claim insurers unfairly refuse pricey hepatitis C drugs

Editor's pick
Seattle Times
3 February 2016
Hepatitis C treatment

Lawmaker: Costly hepatitis C drug "a slap in the face to veterans"

Editor's pick
CBS News
3 February 2016
Harm reduction

President Obama seeks $1.1 billion to fight heroin and opiate epidemic

Editor's pick
The Independent
3 February 2016
HIV prevention policy

Activists United and Ignited by Urgency for HIV Prevention in Europe: EATG and AVAC call for the rollout of PrEP as a proven HIV prevention strategy

Editor's pick
EATG
3 February 2016
Neurological & cognitive problems

Broad range of risk factors associated with mild cognitive impairment in HIV-positive men on ART

News
3 February 2016
The search for a cure

Adenosine deaminase may help the immune system fight HIV on its own

Editor's pick
Eurekalert Medicine & Health
3 February 2016
Drug policy & policing

A simple (ish) guide to the Psychoactive Substances Act

Editor's pick
DrugWatch
3 February 2016
Chemsex & recreational drug use

Chemsex is here to stay

Editor's pick
FS Magazine
3 February 2016
Travel

HIV-Positive Man Mistakenly Denied Tourist Visa To Australia

Editor's pick
Star Observer
3 February 2016
Sexually transmitted infections epidemiology

Zika Infection Transmitted by Sex Reported in Texas

Editor's pick
New York Times
3 February 2016

HIV update - 3rd February 2016

February 2016
Activism & civil society

High-level meeting on HIV/AIDS – how to get involved

Editor's pick
ICASO
2 February 2016
Access to healthcare

Pfizer attempts to mislead public over research and development ‘facts’ with Tube ads

Editor's pick
MSF Access Campaign
2 February 2016
Resistance

Tenofovir resistance may develop in more than half of patients failing treatment in sub-Saharan Africa

News
1 February 2016
PrEP

European Medicines Agency Validates Gilead’s Type II Variation Application for Truvada for Reducing the Risk of Sexually Acquired HIV

Editor's pick
Gilead press release
1 February 2016
Pharmaceutical industry

Merck Throws a Wrench in Drug Pricing

Editor's pick
Bloomberg
1 February 2016
New & experimental hepatitis C treatment

New Merck combination pill Zepatier approved for hepatitis C treatment in the United States

News
1 February 2016
Sex workers

Examining the Implications of PrEP as HIV Prevention for Sex Workers

Editor's pick
Institute of Development Studies
1 February 2016
Treatment guidelines

US: Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Editor's pick
AIDS.info
1 February 2016
Government, leadership & policy

Only 3 Presidential Candidates Share How They Will Address HIV

Editor's pick
HIVPlus
1 February 2016
New & experimental hepatitis C treatment

Zepatier for hepatitis C approved in Canada

Editor's pick
CATIE
1 February 2016
Treatment outcomes & life expectancy

Haitian AIDS Patients' 10-year Survival Equal to American Patients

Editor's pick
Weill Cornell Medical College
1 February 2016
Hepatitis C treatment

European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV

Editor's pick
Bristol-Myers Squibb press release
1 February 2016